title: Are we systematically under-dosing patients with fluorouracil?
authors.affiliation: Johns Hopkins Medical Institutions, Baltimore, MD.
authors.forename: Kalpesh
authors.initials: K
authors.lastname: Patel
authors.affiliation: Johns Hopkins Medical Institutions, Baltimore, MD.
authors.forename: Christine A
authors.initials: CA
authors.lastname: Iacobuzio-Donahue
authors.affiliation: St Agnes Cancer Institute, Baltimore, MD.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Gormley
authors.affiliation: Johns Hopkins Medical Institutions, Baltimore, MD sk@jhmi.edu.
authors.forename: Scott E
authors.initials: SE
authors.lastname: Kern
authors.affiliation: St Agnes Cancer Institute, Baltimore, MD.
authors.forename: Steven C
authors.initials: SC
authors.lastname: Cunningham
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D004334:Drug Administration Schedule; D004379:Duodenal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016577:Pancreaticoduodenectomy
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil